(Q37123406)

18 August 2017

1 reference

title

Pharmacotherapy of acne (English)

1 reference

18 August 2017

0 references

Klaus Degitz

1

1 reference

PubMed ID

18377339

18 August 2017

Falk Ochsendorf

series ordinal

2

1 reference

PubMed ID

18377339

18 August 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

Expert Opinion on Pharmacotherapy

18 August 2017

1 reference

18 August 2017

9

1 reference

18 August 2017

6

1 reference

18 August 2017

955-971

1 reference

Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.

18 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Body dysmorphic disorder symptoms among patients with acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Acne in infancy and acne genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

21 January 2018

Pathophysiology of acne

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Androgen action on human skin -- from basic research to clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Neuroendocrine regulation of sebocytes -- a pathogenetic link between stress and acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Expanding the microcomedone theory and acne therapeutics: Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Propionibacterium Levels In Patients With And Without Acne Vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Inflammatory events are involved in acne lesion initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Acne vulgaris: a disease of Western civilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Acne therapy: a methodologic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Patient compliance: enhancing clinician abilities and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Tricks for improving compliance with acne therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

The critical role of the vehicle to therapeutic efficacy and patient compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

A human retinoic acid receptor which belongs to the family of nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Nuclear receptor that identifies a novel retinoic acid response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Regulation of the expression of epidermal keratinocyte proliferation and differentiation by vitamin A analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Pharmacokinetics and safety of tazarotene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Anophthalmia and agenesis of optic chiasma associated with adapalene gel in early pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

'Keratolytic' properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Topical acne drugs: review of clinical properties, systemic exposure, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Topical antibacterial therapy for acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Treatment of acne with topical antibiotics: lessons from clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Comparative studies on the mechanism of action of lincomycin, streptomycin, and erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Less common methods to treat acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Treatment of acne vulgaris without antibiotics: tertiary amine-benzoyl peroxide combination vs. benzoyl peroxide alone (Proactiv Solution)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Oral antibiotics with antiinflammatory/ immunomodulatory effects in the treatment of various dermatoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Tetracyclines: nonantibiotic properties and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Systemic antibiotic therapy of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Oral contraceptive efficacy and antibiotic interaction: a myth debunked

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Effects of Subantimicrobial-Dose Doxycycline in the Treatment of Moderate Acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Evolution of a strategy for the treatment of acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Seborrhoea--an indicator for poor clinical response in acne patients treated with antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Antibiotic treatment of acne may be associated with upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Strategy of acne therapy with long-term antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

13-cis-retinoic acid competitively inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Isotretinoin effects on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

A double-blind study of the effect of zinc and oxytetracycline in acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

The treatment of acne vulgaris with dapsone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Acne inversa: a dapsone-sensitive dermatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Congenital adrenal hyperplasia and acne in male patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Elevated 17-hydroxyprogesterone serum values in male patients with acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Classification and pharmacology of progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Update and future of hormonal therapy in acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Treatment of acne with antiandrogens--an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Acne vulgaris: lasers, light sources and photodynamic therapy--an update 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

First trimester topical tretinoin and congenital disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

Minocycline and Lupuslike Syndrome in Acne Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.6.955

21 January 2018

Identifiers

DOI

10.1517/14656566.9.6.955

1 reference

18 August 2017

1 reference

PubMed ID

18377339